PNOC and airway hyperresponsiveness: It is worth noting that solid lipid nanoparticles (SLN) were used to encapsulate nociceptin/orphanin FQ for reduction of airway hyperresponsiveness, which is not directly related to pain relief, although the results indicated improved bioavailability and delayed-release [216].